|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
JP2001526648A
(ja)
*
|
1997-04-22 |
2001-12-18 |
コセンシス・インコーポレイテッド |
炭素環及びヘテロ環で置換されたセミカルバゾン及びチオセミカルバゾン、及びその使用
|
|
JP4070955B2
(ja)
*
|
1997-11-21 |
2008-04-02 |
ユーロ−セルティーク エス．エイ． |
置換２−アミノアセトアミドおよびその使用
|
|
GB9727523D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Alpha-aminoamide derivatives useful as analgesic agents
|
|
US6281211B1
(en)
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
CA2370030C
(en)
|
1999-04-09 |
2007-08-14 |
Euro-Celtique S.A. |
Sodium channel blocker compositions and the use thereof
|
|
CA2373944C
(en)
|
1999-05-28 |
2007-07-17 |
Cheil Jedang Corporation |
Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
AR029489A1
(es)
|
2000-03-10 |
2003-07-02 |
Euro Celtique Sa |
Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
|
|
HUP0302893A3
(en)
*
|
2000-08-08 |
2006-04-28 |
Ortho Mcneil Pharm Inc |
Non-imidazole aryloxypiperidines and pharmaceutical compositions containing them and their use
|
|
GB0025208D0
(en)
|
2000-10-13 |
2000-11-29 |
Euro Celtique Sa |
Delayed release pharmaceutical formulations
|
|
PL366114A1
(en)
*
|
2000-10-26 |
2005-01-24 |
Tularik Inc. |
Antiinflammation agents
|
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
AU2002303694A1
(en)
|
2001-05-10 |
2002-11-18 |
Sui Xiong Cai |
Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
US6831193B2
(en)
|
2001-05-18 |
2004-12-14 |
Abbott Laboratories |
Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors
|
|
JP2005508288A
(ja)
*
|
2001-05-18 |
2005-03-31 |
アボット・ラボラトリーズ |
Ｐ２ｘ３およびｐ２ｘ２／３含有受容体を阻害するトリ置換−ｎ−［（１ｓ）−１，２，３，４−テトラヒドロ−１−ナフタレニル］ベンズアミド類
|
|
EP1399159A4
(en)
*
|
2001-06-01 |
2007-02-14 |
Cytovia Inc |
4-SUBSTITUTED 1- (ARYLMETHYLIDEN) THIOSEMICARBAZIDE, 4-SUBSTITUTED 1- (ARYLCARBONYL) THIOSEMICARBAZIDE AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCTORS AND THEIR USE
|
|
JP4350508B2
(ja)
|
2001-09-03 |
2009-10-21 |
ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー |
ガバペンチンまたはその類似体とα−アミノアミドとを含む薬剤組成物およびその鎮痛用途
|
|
AR037233A1
(es)
|
2001-09-07 |
2004-11-03 |
Euro Celtique Sa |
Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
|
|
AR036873A1
(es)
|
2001-09-07 |
2004-10-13 |
Euro Celtique Sa |
Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
|
|
AR040126A1
(es)
|
2002-05-29 |
2005-03-16 |
Glaxo Group Ltd |
Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento
|
|
WO2004060308A2
(en)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Thiosemicarbazones as anti-virals and immunopotentiators
|
|
EP1438956A1
(en)
|
2003-01-16 |
2004-07-21 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful as antimigraine agents
|
|
WO2004066990A2
(en)
*
|
2003-01-30 |
2004-08-12 |
Dynogen Pharmaceuticals, Inc. |
Methods of treating lower urinary tract disorders using sodium channel modulators
|
|
CA2525298A1
(en)
*
|
2003-05-01 |
2004-11-18 |
Panacea Pharmaceuticals, Inc. |
Methods of treating ischemic related conditions
|
|
EP1802623A1
(en)
*
|
2004-10-12 |
2007-07-04 |
Novo Nordisk A/S |
11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
|
|
US8999289B2
(en)
|
2005-03-22 |
2015-04-07 |
President And Fellows Of Harvard College |
Treatment of protein degradation disorders
|
|
AU2006310519A1
(en)
*
|
2005-11-01 |
2007-05-10 |
High Point Pharmaceuticals, Llc |
Pharmaceutical use of substituted amides
|
|
US20090124598A1
(en)
*
|
2005-11-01 |
2009-05-14 |
Henrik Sune Andersen |
Pharmaceutical use of substituted amides
|
|
US8222423B2
(en)
|
2006-02-14 |
2012-07-17 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
MX2008010462A
(es)
|
2006-02-14 |
2009-04-17 |
Harvard College |
Inhibidores de histona desacetilasa.
|
|
US20100168083A1
(en)
*
|
2006-03-21 |
2010-07-01 |
Soren Ebdrup |
Adamantane derivatives for the treatment of the metabolic syndrome
|
|
WO2007115935A1
(en)
|
2006-04-07 |
2007-10-18 |
High Point Pharmaceuticals, Llc |
11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
|
|
AU2007248656B2
(en)
|
2006-05-03 |
2013-04-04 |
Dana-Farber Cancer Institute, Inc. |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
CA2655282A1
(en)
*
|
2006-06-16 |
2007-12-21 |
High Point Pharmaceuticals, Llc |
Pharmaceutical use of substituted piperidine carboxamides
|
|
CA2657078A1
(en)
*
|
2006-07-13 |
2008-01-17 |
High Point Pharmaceuticals, Llc |
11beta-hydroxysteroid dehydrogenase type 1 active compounds
|
|
EP1878721A1
(en)
*
|
2006-07-13 |
2008-01-16 |
Novo Nordisk A/S |
4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
WO2008101886A1
(en)
*
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2146952A1
(en)
*
|
2007-02-23 |
2010-01-27 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
WO2008101907A2
(en)
*
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
CA2675669C
(en)
*
|
2007-02-23 |
2015-05-26 |
High Point Pharmaceuticals, Llc |
Novel compounds
|
|
EA200970841A1
(ru)
*
|
2007-03-09 |
2010-04-30 |
ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Фармацевтическое применение замещенных амидов
|
|
EP2141990A4
(en)
*
|
2007-03-28 |
2011-07-06 |
High Point Pharmaceuticals Llc |
ACTIVE COMPOUNDS ON 11BETA-HSD1
|
|
JP2010523692A
(ja)
*
|
2007-04-11 |
2010-07-15 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
新規合成物
|
|
CA2685036A1
(en)
*
|
2007-04-24 |
2008-11-06 |
High Point Pharmaceuticals, Llc |
Pharmaceutical use of substituted amides
|
|
EP3150589A1
(en)
|
2007-06-08 |
2017-04-05 |
MannKind Corporation |
Ire-1a inhibitors
|
|
ES2447940T3
(es)
*
|
2007-10-15 |
2014-03-13 |
The Salk Institute For Biological Studies |
Métodos para el tratamiento de varias enfermedades y afecciones, y compuestos útiles para los mismos
|
|
KR101708946B1
(ko)
|
2008-07-23 |
2017-02-21 |
다나-파버 캔서 인스티튜트 인크. |
탈아세틸화제 억제제 및 그것의 용도
|
|
DE102008053242A1
(de)
|
2008-10-25 |
2010-05-06 |
Saltigo Gmbh |
Heteroaryl-Arylether
|
|
EA020496B1
(ru)
*
|
2008-11-21 |
2014-11-28 |
ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Производное адамантилбензамида, фармацевтическая композиция, включающая его, и его применение
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
EP2287149A1
(en)
|
2009-08-20 |
2011-02-23 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Enhancers of protein degradation
|
|
DE102010020882A1
(de)
|
2010-05-18 |
2011-11-24 |
Alzchem Trostberg Gmbh |
Semicarbazone zur Härtung von Epoxidharzen
|
|
WO2011158108A2
(en)
|
2010-06-16 |
2011-12-22 |
Purdue Pharma L.P. |
Aryl substituted indoles and the use thereof
|
|
US9120752B2
(en)
|
2010-07-16 |
2015-09-01 |
Purdue Pharma, L.P. |
Pyridine compounds as sodium channel blockers
|
|
BR112013006272A2
(pt)
|
2010-09-17 |
2019-09-24 |
Purdue Pharma Lp |
compostos de piridina e seus usos
|
|
KR20130095772A
(ko)
|
2010-10-05 |
2013-08-28 |
퍼듀 퍼머 엘피 |
나트륨 채널 차단제로서 퀴나졸린 화합물
|
|
CN103347864B
(zh)
|
2010-12-06 |
2016-08-10 |
葛兰素集团有限公司 |
用于治疗由Lp-PLA2介导的疾病或病症的嘧啶酮化合物
|
|
JP2014500303A
(ja)
|
2010-12-22 |
2014-01-09 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ナトリウムチャネル遮断剤としての置換ピリジン
|
|
EP3255041A1
(en)
|
2011-09-02 |
2017-12-13 |
Purdue Pharma L.P. |
Pyrimidines as sodium channel blockers
|
|
AU2012321111A1
(en)
|
2011-10-31 |
2013-05-16 |
Purdue Pharma L.P. |
Quaternized amines as sodium channel blockers
|
|
US9181185B2
(en)
|
2011-10-31 |
2015-11-10 |
Purdue Pharma L.P. |
Heteroaryl compounds as sodium channel blockers
|
|
DE102011118501A1
(de)
|
2011-11-15 |
2013-05-16 |
Alzchem Ag |
Alkyl- oder Dialkyl-Semicarbazone als Härter für Epoxidharze
|
|
US9133131B2
(en)
|
2011-11-15 |
2015-09-15 |
Purdue Pharma L.P. |
Pyrimidine diol amides as sodium channel blockers
|
|
US9206127B2
(en)
|
2012-03-16 |
2015-12-08 |
Purdue Pharm, L.P. |
Substituted pyridines as sodium channel blockers
|
|
AU2013290237A1
(en)
|
2012-07-10 |
2015-01-22 |
Dana-Farber Cancer Institue, Inc. |
Anti-proliferative compounds and uses thereof
|
|
EP2935257B1
(en)
|
2012-12-20 |
2018-02-07 |
Purdue Pharma LP |
Cyclic sulfonamides as sodium channel blockers
|
|
US9637458B2
(en)
|
2013-03-04 |
2017-05-02 |
Jeffrey Lockman |
Pyrimidine carboxamides as sodium channel blockers
|
|
US9120786B2
(en)
|
2013-03-04 |
2015-09-01 |
Purdue Pharma, L.P. |
Triazine carboxamides as sodium channel blockers
|
|
EP2968307A4
(en)
|
2013-03-15 |
2017-01-04 |
Purdue Pharma LP |
Carboxamide derivatives and use thereof
|
|
AU2014262129B2
(en)
|
2013-05-01 |
2018-09-27 |
Neoculi Pty Ltd |
Compounds and methods of treating infections
|
|
CA2922567A1
(en)
|
2013-08-26 |
2015-03-05 |
Purdue Pharma L.P. |
Azaspiro[4.5]decane derivatives and use thereof
|
|
US9359330B2
(en)
|
2013-08-26 |
2016-06-07 |
Purdue Pharma L.P. |
Substituted piperidines as sodium channel blockers
|
|
US9828348B2
(en)
|
2013-11-08 |
2017-11-28 |
Purdue Pharma L.P. |
Benzimidazole derivatives and use thereof
|
|
US9340504B2
(en)
|
2013-11-21 |
2016-05-17 |
Purdue Pharma L.P. |
Pyridine and piperidine derivatives as novel sodium channel blockers
|
|
EP3083606B1
(en)
|
2013-12-20 |
2020-10-28 |
Purdue Pharma LP |
Pyrimidines and use thereof
|
|
US9695144B2
(en)
|
2013-12-23 |
2017-07-04 |
Purdue Pharma L.P. |
Dibenzazepine derivatives and use thereof
|
|
EP3087059B1
(en)
|
2013-12-23 |
2020-04-29 |
Purdue Pharma L.P. |
Indazoles and use thereof
|
|
EP3089978B1
(en)
|
2013-12-30 |
2018-08-29 |
Purdue Pharma L.P. |
Pyridone-sulfone morphinan analogs as opioid receptor ligands
|
|
US10047075B2
(en)
|
2014-01-24 |
2018-08-14 |
Purdue Pharma L.P. |
Pyridines and pyrimidines and use thereof
|
|
EP3105217B1
(en)
|
2014-02-12 |
2019-05-29 |
Purdue Pharma LP |
Isoquinoline derivatives and use thereof
|
|
US10730866B2
(en)
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
|
JP6386088B2
(ja)
|
2014-05-06 |
2018-09-05 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ベンゾモルファン類似体及びその使用
|
|
WO2015192053A1
(en)
|
2014-06-13 |
2015-12-17 |
Purdue Pharma L.P. |
Azamophinan derivatives and use thereof
|
|
US10131666B2
(en)
|
2014-06-13 |
2018-11-20 |
Purdue Pharma L.P. |
Heterocyclic morphinan derivatives and use thereof
|
|
US10745402B2
(en)
|
2017-01-02 |
2020-08-18 |
Purdue Pharma L.P. |
Morphinan derivatives and use thereof
|